271 related articles for article (PubMed ID: 1645725)
1. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
[TBL] [Abstract][Full Text] [Related]
2. Novel leukocyte agonists are released by endothelial cells exposed to peroxide.
Patel KD; Zimmerman GA; Prescott SM; McIntyre TM
J Biol Chem; 1992 Jul; 267(21):15168-75. PubMed ID: 1321830
[TBL] [Abstract][Full Text] [Related]
3. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.
Stremler KE; Stafforini DM; Prescott SM; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11095-103. PubMed ID: 2040620
[TBL] [Abstract][Full Text] [Related]
4. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
5. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
6. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
8. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
[TBL] [Abstract][Full Text] [Related]
9. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants.
Kowanko IC; Bates EJ; Ferrante A
Arthritis Rheum; 1992 Aug; 35(8):918-25. PubMed ID: 1322671
[TBL] [Abstract][Full Text] [Related]
11. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
12. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
Tordai A; Franklin RA; Johnson C; Mazer BD; Clay KL; Gelfand EW
J Immunol; 1994 Jan; 152(2):566-73. PubMed ID: 8283038
[TBL] [Abstract][Full Text] [Related]
13. Activation of vascular cells by PAF-like lipids in oxidized LDL.
Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM
Vascul Pharmacol; 2002 Apr; 38(4):193-200. PubMed ID: 12449015
[TBL] [Abstract][Full Text] [Related]
14. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally.
Lee YM; Hybertson BM; Cho HG; Terada LS; Cho O; Repine AJ; Repine JE
Am J Physiol Lung Cell Mol Physiol; 2000 Jul; 279(1):L75-80. PubMed ID: 10893205
[TBL] [Abstract][Full Text] [Related]
17. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
18. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
